Malaria market research reports by Market Xcel

India Malaria Vaccine Market Assessment, By Agent [Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae, Plasmodium Ovale, Plasmodium Knowlesi], By Stage Targeted [Pre-erythrocytic vaccines, Erythrocytic vaccines, Transmission-blocking vaccines, By Type of Vaccine [Whole Organism Vaccine and Protein Subunit Vaccine], By Technology [mRNA and Recombinant], By Route of Administration [Intramuscular, Subcutaneous, Intradermal, Others], By End-user [Hospitals, Specialty clinics, Homecare, Others], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy Government, Non-Governmental Organisations], By Region, By Opportunities and Forecast, FY2017-FY2031

Aug 22, 2023  |  Published by: Market Xcel  |  USD 3,300

India Malaria Vaccine market size was valued at USD 125.2 million in FY2023, which is expected to reach USD 215.44 million in FY2031 with a CAGR of 7.02% for the forecast period between FY2024-FY2031. According to the WHO, India had a significant share in global malaria cases and deaths in 2021. Ind ... Read More